Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teleflex Incorporated Common Stock (NY:TFX)

120.78 -0.38 (-0.31%)
Streaming Delayed Price Updated: 3:20 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
TFX Q2 Deep Dive: Interventional Growth and Strategic Portfolio Shifts Define Outlook
Medical technology company Teleflex (NYSE:TFX) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.3% year on year to $780.9 million. Its non-GAAP profit of $3.73 per share was 10.8%... 
Via StockStory
Topics World Trade
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
3 Value Stocks with Questionable Fundamentals
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
Earnings Scheduled For July 31, 2025
 
Via Benzinga
How Is The Market Feeling About Teleflex?
 
Via Benzinga
Teleflex Inc (NYSE:TFX) Recognized as a Strong Value Investment with Solid Fundamentals
Teleflex Inc (NYSE:TFX) is a solid value stock with strong profitability, reasonable valuation, and stable financials, offering a potential safety net for investors. 
Via Chartmill
Deep Dive Into Teleflex Stock: Analyst Perspectives (7 Ratings)
 
Via Benzinga
Teleflex Inc (NYSE:TFX) Beats Q2 2025 Earnings Estimates with Strong Revenue and EPS Growth
Teleflex (NYSE:TFX) beats Q2 2025 estimates with $780.9M revenue and $3.73 EPS, driving a 15.9% pre-market surge. Strong growth in medical tech sector. 
Via Chartmill
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex (NYSE:TFX) Beats Q2 Sales Targets
Medical technology company Teleflex (NYSE:TFX) announced better-than-expected revenue in Q2 CY2025, with sales up 2.3% year on year to $780.9 million. Its non-GAAP profit of $3.73 per share was 10.8%... 
Via StockStory
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
From Teleflex Incorporated
Via GlobeNewswire
Teleflex (TFX) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday before market hours. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
1 Oversold Stock Set for a Comeback and 2 We Ignore
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
3 Small-Cap Stocks with Questionable Fundamentals
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
 
Via Benzinga
TELEFLEX INC (NYSE:TFX) – A Potentially Undervalued Stock with Solid Fundamentals
TELEFLEX INC (NYSE:TFX) appears undervalued with strong profitability and financial health, making it a potential candidate for value investors. 
Via Chartmill
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business
From Teleflex Incorporated
Via GlobeNewswire
3 Profitable Stocks Facing Headwinds
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
From Teleflex Incorporated
Via GlobeNewswire
3 Healthcare Stocks with Questionable Fundamentals
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Retirement Stocks
Teleflex Publishes 2024 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
TFX Q1 Earnings Call: Guidance Cut and Strategic Shifts Dominate Amid Tariff Headwinds
Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9%... 
Via StockStory
Topics Economy World Trade
New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Q1 Earnings Highlights: Teleflex (NYSE:TFX) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
Teleflex (NYSE:TFX) Reports Q1 In Line With Expectations
Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9%... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.